NCT01433510View on ClinicalTrials.gov

Tolerability of Grazax in Patients With Hayfever in Real Life Settings

PHASE4CompletedINTERVENTIONAL
Enrollment

628

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

December 31, 2010

Conditions
Allergic Rhinoconjunctivitis
Interventions
DRUG

Grazax

1 tablet/day - pre and co-seasonal

Trial Locations (1)

44000

Centre Hospitalier Universitaire, Nantes

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT01433510 - Tolerability of Grazax in Patients With Hayfever in Real Life Settings | Biotech Hunter | Biotech Hunter